Lonza Group AG/€LONN

05:30
08:40
11:45
14:55
18:00
1D1W1MYTD1Y5YMAX

About Lonza Group AG

Lonza Group AG is a global company specializing in pharmaceutical, biotech, and nutrition sectors, headquartered in Basel, Switzerland. It provides integrated solutions for the creation of new drugs, ranging from active pharmaceutical ingredients (APIs) and drug formulation to drug delivery systems. The company serves a diverse clientele including pharmaceutical and biotech companies, offering contract development and manufacturing organization (CDMO) services. With operations in multiple countries, Lonza is strategically positioned to cater to global healthcare needs. Known for its extensive capabilities in cell and gene therapy, the organization leverages advanced technology platforms to support complex biopharmaceutical developments, enhancing its competitive edge in the industry.

Ticker

€LONN
Sector

Primary listing

XGAT

Employees

19,299

Headquarters

Basel, Switzerland

Lonza Group AG Metrics

BasicAdvanced
€42B
53.35
€11.10
0.80
€4.28
0.36%

Bulls say / Bears say

Lonza’s CDMO business posted growth that was restrained by weaker demand in cell & gene technologies and microbial products during the first half of 2025, signaling possible challenges in newer treatment areas (Reuters).
The company projects a negative currency impact of –2.5% to –3.5% on both sales and CORE EBITDA for FY 2025, due to a weaker U.S. dollar, pointing to considerable foreign exchange risk (Reuters).
Analysts believe Lonza’s Capsules & Health Ingredients division could be valued at CHF 2–4 billion if sold, but management has emphasized it is too early to set a clear value, adding strategic and valuation uncertainty (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 1 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy €LONN

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs